CX Institutional’s Organon & Co OGN Stock Holding History

CX Institutional’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1K	Buy	65 +15	+30%	+$205	﹤0.01%	1639
2026 Q2	$1K	Sell	50 -142	-74%	-$1.7K	﹤0.01%	1540
2026 Q1	$1K	Buy	192 +1	+0.5%	+$8	﹤0.01%	1523
2025 Q4	$1K	Sell	191 -269	-58%	-$2.12K	﹤0.01%	1478
2025 Q3	$5K	Buy	460 +70	+18%	+$687	﹤0.01%	1263
2025 Q2	$4K	Hold	390	–	–	﹤0.01%	1116
2025 Q1	$6K	Buy	+390	New	+$6K	﹤0.01%	1054
2022 Q3	–	Sell	-1,430	Closed	-$48K	–	931
2022 Q2	$48K	Buy	+1,430	New	+$50.1K	﹤0.01%	683
2021 Q4	–	Sell	-1,161	Closed	-$38K	–	741
2021 Q3	$38K	Sell	1,161 -1,111	-49%	-$35.5K	﹤0.01%	635
2021 Q2	$69K	Buy	+2,272	New	+$74.8K	0.01%	501

Other funds holding OGN

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Fruth Investment Management Houston, Texas $409M AUM 32.01% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return

Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

CX Institutional's OGN Position: Q3 2026 in Review

CX Institutional increased its Organon & Co (OGN) stake by 30% in Q3 2026, buying an estimated $205 and bringing the position to 65 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

CX Institutional first reported a position in OGN in Q2 2021 and has held it in 10 quarters since. The position peaked at $69K in Q2 2021. 90 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

CX Institutional held 65 shares of Organon & Co worth $1K as of Q3 2026.
CX Institutional bought 15 Organon & Co shares in Q3 2026, an estimated $205.
Organon & Co made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1639 holding.
CX Institutional first reported a position in Organon & Co in Q2 2021 and has held it in 10 quarters since.
CX Institutional's Organon & Co position peaked at $69K in Q2 2021.
90 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.